Study examines GLP-1 agonists and bowel preparation quality in type 2 diabetes
The paper, published by Baishideng Publishing Group, looks at colonoscopy prep adequacy in patients with type 2 diabetes taking incretin drugs.
PR
By Priya Raman · Science Reporter
Oct 19 22:28 ETSource: Baishideng Publishing Group
The wire
- 01Researchers assessed how glucagon-like peptide-1 receptor agonist use relates to bowel preparation quality for colonoscopy among patients with type 2 diabetes.
- 02Endoscopy units and prescribers have been weighing periprocedural GLP-1 handling because of delayed gastric emptying and retained gastric contents.
- 03Full methods, sample size and effect estimates are needed before the findings should alter prep or scheduling protocols.
From the source
Read at wjgnet.comImpact of glucagon-like peptide-1 receptor agonists on bowel preparation quality for colonoscopy in type 2 diabetes
